Michael Tremblay
Director/Board Member at KNIGHT THERAPEUTICS INC.
Net worth: 8 350 $ as of 2024-04-29
Network origin in Michael Tremblay first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 14 | |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada.
7
| Private Company | Miscellaneous Commercial Services | 7 |
Astellas Pharma Canada, Inc.
 Astellas Pharma Canada, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Canada, Inc. is a pharmaceutical company. It offers immunology, anti infective, cardiology, oncology and research and development products. The company is headquartered in Markham, Canada.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Tremblay via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| McGill University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| PALADIN LABS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director of Finance/CFO Corporate Officer/Principal Director of Finance/CFO Public Communications Contact | |
| BIOTOSCANA INVESTMENTS S.A. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| ANTIBE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
| University of Ottawa | College/University | Masters Business Admin Undergraduate Degree | |
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Medison Biotech 1995 Ltd. | Director/Board Member Chief Executive Officer | ||
| PFENEX INC. | Biotechnology | Chairman Director/Board Member | |
| The University of Chicago | College/University | Masters Business Admin Graduate Degree | |
| Richard Ivey School of Business | College/University | Masters Business Admin Undergraduate Degree | |
| University of Guelph | College/University | Undergraduate Degree Undergraduate Degree | |
| PROFOUND MEDICAL CORP. | Medical Specialties | Director/Board Member Director/Board Member | |
| Universidad Torcuato di Tella | College/University | Undergraduate Degree | |
BioQuebec
 BioQuebec BiotechnologyHealth Technology BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun. | Biotechnology | Director/Board Member | |
| ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| THERATECHNOLOGIES INC. | Pharmaceuticals: Major | President | |
H&P Labs, Inc.
 H&P Labs, Inc. Miscellaneous Commercial ServicesCommercial Services H&P Labs, Inc. operates as a biotechnology firm. It develops drugs to fight infectious viral diseases for public health and biodefense missions. The company was founded by John Michel T. Huss on June 7, 2013 and is headquartered in Westmount, Canada. | Miscellaneous Commercial Services | Founder | |
Prisma Medios de Pago SAU
 Prisma Medios de Pago SAU Finance/Rental/LeasingFinance Prisma Medios de Pago SA provides credit card issuing services. Its service portfolio includes issuing visa debit card and transaction processing services. The company was founded in 2014 and is headquartered in Buenos Aires, Argentina. | Finance/Rental/Leasing | Director/Board Member | |
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman | |
| HSBC Latin America Private Equity Investors GP LP | Corporate Officer/Principal | ||
Clara Capital SA
 Clara Capital SA Investment ManagersFinance Clara Capital SA (Clara Capital) is an independent private equity firm. The company is founded in 2012 and is headquartered in Buenos Aires, Argentina. | Investment Managers | Private Equity Investor | |
| Advent International (Argentina) | Director/Board Member | ||
Valera Pharmaceuticals, Inc.
 Valera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Valera Pharmaceuticals, Inc. develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders. The Company was founded in 1972 and is located in Cranbury, NJ. | Pharmaceuticals: Major | Chairman | |
Scotiabank Uruguay SA
 Scotiabank Uruguay SA Major BanksFinance Scotiabank Uruguay SA is a financial company. It is engaged in offering banking services such as personal loans, car loans, corporate loans, credit cards, online and telebanking services, and export and import finance services to corporate and retail customers. The company was founded in 2002 and is headquartered in Montevideo, Uruguay. | Major Banks | Director/Board Member | |
| ALLON THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Bar-Ilan University | College/University | Undergraduate Degree | |
| University of Bradford | College/University | Masters Business Admin | |
| ALPHA TAU MEDICAL LTD. | Medical Specialties | Director/Board Member | |
Discreet Logic, Inc.
 Discreet Logic, Inc. Packaged SoftwareTechnology Services Part of Autodesk, Inc., Discreet Logic, Inc. is a Canadian company that develops animation software. The private company is based in Montréal, Canada. The company was founded by Tom Cantwell, Raju Bopardikar. Discreet Logic was acquired by Autodesk, Inc. on March 16, 1999 for $411.40 million. | Packaged Software | Corporate Officer/Principal | |
| Labopharm USA, Inc. | Director/Board Member | ||
| NUVO PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| CRESCITA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
ViRexx Medical Corp.
 ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| ONCOLYTICS BIOTECH INC. | Biotechnology | Director/Board Member | |
McGill University Health Center
 McGill University Health Center Hospital/Nursing ManagementHealth Services McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada. | Hospital/Nursing Management | Director/Board Member | |
Montreal Society For The Prevention of Cruelty To Animals
 Montreal Society For The Prevention of Cruelty To Animals Agricultural Commodities/MillingProcess Industries The Montreal Society for the Prevention of Cruelty to Animals is an organization that aims to make a difference in the lives of animals. The non-profit company is based in Montreal, Canada. The Canadian company's mission is to prevent cruelty to animals, and they offer a sterilization clinic for animals. | Agricultural Commodities/Milling | Director/Board Member | |
| DOLLARAMA INC. | Department Stores | Director/Board Member | |
| MICROBIX BIOSYSTEMS INC. | Biotechnology | Chief Operating Officer | |
| The University of Sheffield | College/University | Undergraduate Degree | |
| University of London | College/University | Doctorate Degree | |
| Itp Biomedica Corp. | Chief Executive Officer | ||
PlantForm Corp.
 PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Founder | |
| Roker Biotechnologies, Inc. | Founder | ||
| CARDIOL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
Accelera Canada Ltd.
 Accelera Canada Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Eversana Life Science Services LLC, Accelera Canada Ltd. is a full-service firm providing end-to-end commercialization for emerging biotechnology and life science ventures. The private company is based in Toronto, Canada. Accelera Canada was acquired by Eversana Life Science Services LLC on July 26, 2021. With senior leadership comprised of former pharmaceutical executives with North American and international experience, Accelera is uniquely positioned to provide strategic guidance and support to companies entering the Canadian healthcare market. | Miscellaneous Commercial Services | Director/Board Member | |
| Concordia University | College/University | Graduate Degree | |
| CANADIAN NATIONAL RAILWAY COMPANY | Railroads | Comptroller/Controller/Auditor |
Statistics
International
| Canada | 31 |
| United States | 6 |
| Argentina | 5 |
| United Kingdom | 5 |
| Israel | 4 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 12 |
| Commercial Services | 5 |
| Finance | 4 |
| Technology Services | 2 |
Operational
| Director/Board Member | 114 |
| Corporate Officer/Principal | 37 |
| Independent Dir/Board Member | 31 |
| Chairman | 19 |
| Undergraduate Degree | 19 |
Most connected contacts
| Insiders | |
|---|---|
| James Gale | 45 |
| Jonathan Goodman | 25 |
| Samira Sakhia | 17 |
| Kevin Cameron | 17 |
| Janice Murray | 13 |
| Deborah Brown | 13 |
| Robert N. Lande | 11 |
| Frédéric Fasano | 9 |
| Nicolás Sujoy Spiguel | 8 |
| Kenneth Hughes | 8 |
| Amal Khouri | 7 |
| Meir Jakobsohn | 6 |
| Leopoldo Bosano | 6 |
| John-Michel Huss | 6 |
| Chris Halyk | 5 |
- Stock Market
- Insiders
- Michael Tremblay
- Company connections